UBS AM’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,500	Closed	-$298K	–	2790
2021 Q1	$298K	Sell	13,500 -5,500	-29%	-$121K	﹤0.01%	2486
2020 Q4	$588K	Buy	+19,000	New	+$588K	﹤0.01%	2245